Great post Milo. I appreciate your time and efforts to share your insight and experiences with us. I'm VERY excited to be a 'long' and just want to thank you, again.
You don't know if Hirsch has been truthful to you because there isn't any information from Hirsch that can be independently verified.
Bignitz was desperate to create volume for DGF so they could dump more shares - that is why they told you about the updated clinicaltrials.gov - you posted about the update the same day they provided the update.
But the funniest part is that it was much Ado about Nothing - as usual OWCP didn't post any results.
There is absolutely no proof that the Phase 1 study has been started or completed.
Where is the efficacy report that was supposed to be completed by January 2017?
The reverse split will be a disaster for shareholders.
OWCP can't uplist to Nasdaq (Nasdaq Capital Market) - the price is meaningless - Hirsch is lying about uplisting.